Coronary Artery Disease
Showing NaN - NaN of 132
Coronary Artery Disease Trial in Beijing (Intravascular imaging)
Recruiting
- Coronary Artery Disease
- Intravascular imaging
-
Beijing, Chaoyang District, China
- +3 more
May 28, 2021
Coronary Artery Disease Trial in Beijing (paclitaxel DCB, DES)
Not yet recruiting
- Coronary Artery Disease
- paclitaxel DCB
- DES
-
Beijing, Beijing, ChinaPeking University Third Hospital
Apr 9, 2021
Stroke, Ischemic, Coronary Artery Disease, Angina Pectoris, Stable Trial in Beijing (Buqitongluo Granule, Buqitongluo Granule
Recruiting
- Stroke, Ischemic
- +3 more
- Buqitongluo Granule
- +2 more
-
Beijing, Beijing, ChinaDongzhimen Hospital
Mar 29, 2021
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Beijing (Enoxaparin (Staged-dose PCI Group), Enoxaparin
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Enoxaparin (Staged-dose PCI Group)
- +3 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 26, 2021
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Beijing (Berberine, Standard treatment, Aspirin)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Berberine
- +3 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 26, 2021
Bleeding Disorder, Stroke, Ischemic, Stroke Hemorrhagic Trial in Worldwide (XIENCE, DAPT)
Coronary Artery Disease Trial in China (The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System)
Not yet recruiting
- Coronary Artery Disease
- The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
-
Beijing, Beijing, China
- +4 more
Feb 23, 2021
Radial Artery Occlusion, Coronary Artery Disease Trial in Beijing (7-Fr Glidesheath Slender, Cordis 7-Fr radial sheath)
Not yet recruiting
- Radial Artery Occlusion
- Coronary Artery Disease
- 7-Fr Glidesheath Slender
- Cordis 7-Fr radial sheath
-
Beijing, Beijing, ChinaFuwai Hospital National Center for Cardiovascular Diseases
Feb 8, 2021
Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention Trial in Beijing (drug, device, other)
Enrolling by invitation
- Coronary Artery Disease
- +4 more
- aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- +3 more
-
Beijing, Beijing, ChinaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medic
Feb 6, 2021
Coronary Artery Disease Trial in Beijing
Completed
- Coronary Artery Disease
-
Beijing, Chinacenter of pulmonary vascular disease, Fuwai hospital
Feb 3, 2021
Coronary Artery Disease Trial in China (SYNERGY Investigational Device, PE Plus Investigational Device)
Completed
- Coronary Artery Disease
- SYNERGY Investigational Device
- PE Plus Investigational Device
-
Beijing, China
- +13 more
Dec 29, 2020
Coronary Artery Disease, Stroke, Atrial Fibrillation Trial in Beijing (Left Atrial Appendage Resection and Marshall Ligament
Recruiting
- Coronary Artery Disease
- +2 more
- Left Atrial Appendage Resection and Marshall Ligament Amputation
-
Beijing, ChinaFuwai Hospital
Jan 19, 2021
Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Coronary Artery Disease Trial in Beijing
Unknown status
- Chronic Total Occlusion of Coronary Artery
- +3 more
- aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- coronary wires. stents or coronary balloons
-
Beijing, ChinaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medic
Aug 29, 2020
Coronary Artery Disease Trial in Beijing (No-Touch vein harvesting technique, Conventional vein harvesting)
Unknown status
- Coronary Artery Disease
- No-Touch vein harvesting technique
- Conventional vein harvesting
-
Beijing, Beijing, ChinaFuwai Hospital Chinese Academay of Medical Science and National
Jul 12, 2020
Coronary Artery Disease Trial in Beijing (OCT-guided paclitaxel drug-coated balloon angioplasty, Angiography-guided paclitaxel
Unknown status
- Coronary Artery Disease
- OCT-guided paclitaxel drug-coated balloon angioplasty
- Angiography-guided paclitaxel drug-coated balloon angioplasty
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Feb 18, 2020
Coronary Artery Disease, In Stent Restenosis Trial in China (drug-coated balloon Catheter)
Unknown status
- Coronary Artery Disease
- In Stent Restenosis
- drug-coated balloon Catheter
-
Hefei, An Hui, China
- +18 more
Feb 17, 2020
Genetics and Biomarkers of Acute Coronary Syndrome
Unknown status
- Coronary Artery Disease
- +3 more
-
Beijing, China
- +4 more
Dec 31, 2019
Coronary Artery Disease, Antineoplastic Agents Trial in China (study group, control group)
Active, not recruiting
- Coronary Artery Disease
- Antineoplastic Agents
- study group
- control group
-
Beijing, Beijing, China
- +24 more
Nov 19, 2019
Coronary Artery Disease, Gastroesophageal Reflux Disease Trial in Beijing (Indobufen and aspirin mimetic, Aspirin and indobufen
Unknown status
- Coronary Artery Disease
- Gastroesophageal Reflux Disease
- Indobufen and aspirin mimetic
- Aspirin and indobufen mimetic
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Oct 14, 2019
Coronary Artery Disease Trial in Beijing (Ticagrelor, ticagrelor, clopidogrel)
Coronary Artery Disease, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors Trial in China (Vicagrel 5mg,
Completed
- Coronary Artery Disease
- +2 more
- Vicagrel 5mg
- +3 more
-
Bengbu, Anhui, China
- +26 more
Sep 19, 2019
Coronary Artery Disease Trial in Beijing
Completed
- Coronary Artery Disease
-
Beijing, Chinacenter of pulmonary vascular disease, Fuwai hospital
Sep 14, 2019
Coronary Artery Disease Trial in Beijing (FIREHAWK biodegradable polymer rapamycin-eluting stent)
Completed
- Coronary Artery Disease
- FIREHAWK biodegradable polymer rapamycin-eluting stent
-
Beijing, ChinaFuwai Hospital
Aug 12, 2019
Coronary Artery Disease Trial in Beijing (CT-FFR)
Unknown status
- Coronary Artery Disease
- CT-FFR
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Aug 19, 2019
Facial Characteristics and Coronary Artery Diseases
Completed
- Coronary Artery Disease
- No intervention
-
Beijing, Beijing, China
- +8 more
Aug 17, 2019